Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pericarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Rheumatic Heart Disease III: Medical Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 16, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Thomas Vockenhuber1, Lukas Baldinger1, Johannes Clausen2
1Department of Cardiology, Angiology and Internal Intensive Care Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria.
Immune checkpoint inhibitor (ICI) therapy can cause severe myocarditis. Ruxolitinib showed promise in a steroid-refractory case, improving heart function and arrhythmias.
Area of Science:
Background:
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018